Infusion Blog
There are big changes coming from CMS with a major update to ICD-10 code G35 for multiple sclerosis. For years, all MS patients were captured under […]
AUSTIN, Texas (September 9, 2025) — The overwhelming majority of small and independent healthcare providers fear that Medicare’s upcoming negotiation of Part B drug prices could […]
Author: Ashley Knapp Whether you’re a clinician, administrator, patient, or industry partner, advocacy is a powerful tool to protect and strengthen the future of office-based infusion […]
Every August, members of Congress return to their home districts, creating a valuable opportunity to share how federal policies impact your infusion practice and the patients […]
Running an infusion center is about more than just administering treatments—it’s about creating a network of trust with patients who rely on these therapies to manage their health conditions. One of the most effective ways to reach potential patients and grow your business is by connecting with them directly.
Running an infusion center is about more than just administering treatments—it’s about creating a network of trust with patients who rely on these therapies to manage their health conditions. One of the most effective ways to reach potential patients and grow your business is by connecting with them directly.
Entering the infusion therapy market presents both exciting opportunities and formidable challenges. From high upfront drug costs to complex reimbursement rules, new entrants must strike a careful balance to achieve profitability and maintain patient satisfaction.
Infusion providers should know the U.S. Department of Health and Human Services (HHS) published through its Office for Civil Rights (OCR) a new proposed rule to modify the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Security Rule (Proposed Rule) for the first time since 2013 (the original rule was published in 2003).
The current standard of care around IV monitoring is to “wait and see” if an injury occurs. This is simply not acceptable – especially in cases […]